What is Repligen's EV / EBITDA?

Repligen (RGEN) reported EV / EBITDA of 98.4× in Q3 2024.

How has Repligen's EV / EBITDA changed year-over-year?

Repligen's EV / EBITDA increased by 99.6% year-over-year, from 49.3× to 98.4×.

What is the long-term trend for Repligen's EV / EBITDA?

Over 3 years (2020 to 2023), Repligen's EV / EBITDA has grown at a -11.7% compound annual growth rate (CAGR), from 102.3× to 70.4×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Repligen RGEN EV / EBITDA

EV / EBITDA at other companies

Thermo Fisher ScientificTMO

21.3×-3.5×

DanaherDHR

20.5×-2.1×

Maravai LifeSciences Holdings, Inc.MRVI

195.6×+190×

Charles River LaboratoriesCRL

16.2×+2.9×

TEC

Bio-TechneTECH

33.8×+2.6×

RevvityRVTY

16.7×-2.2×

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

Operating cash flow$28.3M+88.6%

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.7B+15.1%

Enterprise value$7.8B+26.7%

P/E149.7×—

P/S10.5×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Calculated from Repligen’s reported figures.

enterprise value/ebitda=98.4×

Based on the most recent quarter.

The official record: Repligen’s 10-Q, filed November 18, 2024, on SEC EDGAR. View the filing →

Ask your AI about Repligen's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's EV / EBITDA?: Repligen (RGEN) reported EV / EBITDA of 98.4× in Q3 2024.
How has Repligen's EV / EBITDA changed year-over-year?: Repligen's EV / EBITDA increased by 99.6% year-over-year, from 49.3× to 98.4×.
What is the long-term trend for Repligen's EV / EBITDA?: Over 3 years (2020 to 2023), Repligen's EV / EBITDA has grown at a -11.7% compound annual growth rate (CAGR), from 102.3× to 70.4×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.